Cytotoxic and antioxidant effects of methoxylated stilbene analogues on HepG2 hepatoma and Chang liver cells: Implications for structure activity relationship

Human and Experimental Toxicology

Volumn 30, Issue 2, 2011, Pages 138-144

  Hasiah, A H ^a   Ghazali, A R ^a   Weber, J F F ^b   Velu, S ^b   Thomas, N F ^c   Inayat Hussain, S H ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

antioxidant; Chang liver cells; cytotoxicity; HepG2 hepatoma cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 METHOXY 4' HYDROXYSTILBENE; 3,4',5 TRIMETHOXYSTILBENE; 3,4,4' TRIMETHOXYSTILBENE; 3,5 DIMETHOXY 4' HYDROXYSTILBENE; 4 METHOXY 4' HYDROXYSTILBENE; 4,4' DIMETHOXYSTILBENE; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FERRIC REDUCING ANTIOXIDANT POWER ASSAY; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; LIVER; MOLECULAR STRUCTURE; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78651068987     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110368739     Document Type: Article

References (21)

1. Scalbert A., Manach C., Morand C., Remesy C., Jimenez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005 ; 45: 287-306.
2. Roupe KA, Remsberg CM, Yanez JM, Davies NM Pharmacometric of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 2006 ; 1: 81-101.
3. Jang M., Cai L., Udeani GO, Slowing KV, Thomas CF, Beecher CW Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997 ; 275: 218-220.
4. Aziz HM, Kumar R., Ahmad N. Cancer chemoprevention by resveratrol In vitro and in vivo studies and underlying mechanisms (Review). Int J Oncol 2003 ; 23: 17-28.
5. Aggarwal BB, Bhardwaj A., Aggarwal RS, Seeram NP, Shishodia S., Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anti-Cancer Res 2004 ; 24: 2783-2740.
6. Athar M., Back JH, Tang X., Kim KH, Kopelovich L., Bickers DR, et al. Resveratrol. A review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007 ; 224: 274-283.
7. Kundu JK, Surh YJ Cancer chemoprevention with dietary phytochemicals. Mutat Res 2004 ; 555: 65-80.
8. Kundu JK, Surh YJ Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett 2008 ; 269: 243-261.
9. Inayat-Hussain SH, Thomas NF Recent advances in discovery and development of stilbenes and lactone in anticancer therapy. Expert Opin Ther Pat 2004 ; 14: 1-17.
10. Ovesna Z., Horvathova K. Structure-activity relationship of trans-resveratrol and its analogues (Minireview). Neoplasma 2005 ; 52: 450-455.
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Aplication to proliferation and cytotoxicity assays. J Immunol Meth 1983 ; 65: 58-63.
12. Benzie IFF, Strain JJ The ferric reducing ability of plasma (FRAP) as a measure of "Antioxidant Power": The FRAP assay. Anal Biochem 1996 ; 239: 70-76.
13. Roberti M., Pizzirani D., Simoni D., Rondanin R., Baruchello R., Bonora C., et al. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J Med Chem 2003 ; 46: 3546-3554.
14. Tolomeo M., Grimaudo S., Di Cristina A., Roberti M., Pizzirani D., Meli M., et al. Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int J Biochem Cell Biol 2005 ; 37: 1709-1726.
15. Firuzi O., Lacanna A., Petrucci R., Marrosu G., Saso L. Evaluation of the antioxidant activity of flavonoids by "ferric reducing antioxidant power" assay and cyclic voltammetry. Biochim Biophys Acta 2005 ; 1721: 174-184.
16. Murias M., Jager W., Handler N., Erker T., Horvath Z., Szekeres T., et al. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure activity relationship. Biochem Pharmacol 2005 ; 69: 903-912.
17. Ashikawa K., Majumdar S., Banarjee S., Bharti AC, Shishoda S., Aggarwal BB Piceatannol inhibit TNFinduced expression through suppression of IKappa B alpha kinase and p65 phosphorylation. J Immunol 2002 ; 169: 6490-6497.
18. Rice-Evans CA, Miller NJ, Panganga G. Structure-antioxidant activity relationships of flavanoids and phenolic acids. Free Radic Biol Med 1996 ; 20: 933-956.
19. Spencer JP, Abd-el-Mohsen MM, Rice-Evans CA Cellular uptake and metabolism of flavanoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys 2004 ; 423: 148-161.
20. Lima FC, Fernandes-Ferreira M., Pereira-Wilson C. Phenolic compounds protect HepG2 cells from oxidative damage: relevance of glutathione levels. Life Sci 2006 ; 79: 2056-2068.
21. Griffin PS, Bhagooli R. Measuring antioxidant potential in corals using the FRAP assay. J Exper Marine Biol Ecol 2004 ; 302: 201-211.